This report incorporates an in-depth analysis of the microarray market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for medical device technologies.
The scope of the report is limited to only those microarray markets that generate the most global revenue. Genomics and proteomics and the NGS market are already covered in other BCC Research reports, so these have been excluded.
This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific and the Rest of the World region. For market estimates, data is provided for the base year 2021, and forecast through 2027.
- 76 total tables
- A comprehensive overview and up-to-date analysis of the global microarray market
- Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential for global microarray industry, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for microarrays in USD million values, and corresponding market share analysis by product type, application and geographic region
- In-depth information on the major market drivers and opportunities, industry shifts and regulations, and other demographic factors that will influence this market demand in the coming years (2022-2027)
- Insight into the major technology updates, issues and risks, government regulations, breakthrough innovations, collaborations and developments, and costs and benefits of microarrays in the genomics industry
- Holistic review of the COVID-19 pandemic impact on microarray technologies market
- Updated information on the technology landscape of microarrays market, novel products launch, new and emerging applications in the life sciences, and ongoing clinical trials etc.
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the market leading players, including Geron, Epic Sciences Inc., Genexine, Commence Bio and Vitatex Inc.
The global market for microarrays had a value at $REDACTED billion in 2021. This market is anticipated to grow at a compound annual growth rate (CAGR) of REDACTED% over the forecast period to reach $REDACTED billion by the end of 2027.
Microarray technology has a broad range of applications in the field of medicine. Scientists worldwide are currently involved in many forms of research that is aimed at the development of more general applications of microarray technology. The microarray is presently used in three broad areas: biotechnological and other research; medical diagnosis and treatment; crime and security.
A rise in ongoing R&D, increase in government spending, growing healthcare expenditures, the need for early cancer detection and diagnosis and large-scale DNA/gene chip initiatives are expected to drive the market for microarrays. In addition, the adoption of personalized medicines, a wider range of application areas and technological advances are expected to drive the demand for microarrays. However, the complexity of data obtained through DNA microarray analysis and the lack of skilled professionals are some of the major factors restraining the growth of the global microarray market.
The demand for COVID-19 vaccines has been increasing due to the rise in the number of COVID cases across the globe. This has led to increased demand for microarray technology, because it can be used to create molecular tests to detect the coronavirus and to map the antibody for COVID-19.
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 Information Sources
1.6 Geographic Breakdown
1.7 Analyst’s Credentials
1.8 BCC Custom Research
1.9 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
2.2 Classification of Microarrays Based on Mode of Preparation
2.3 Types of Microarrays Used in Different Probes
2.4 DNA Microarrays
2.4.1 How a DNA Microarray Works
2.4.2 DNA Microarray Types
2.4.3 DNA Microarray Applications
2.4.4 SNP Analysis
2.4.5 Epigenetic Analysis
2.4.6 Cytogenetic Analysis
2.4.7 Micro-RNA Analysis
2.4.8 Bead-Based Arrays
2.4.9 Catalog and Custom DNA Microarrays
2.5 Protein Microarray Technologies
2.5.2 Proteomics Workflow
2.5.3 Protein Microarray Design
2.5.4 Applications of Protein Microarrays
2.5.5 Types of Protein Microarrays
2.5.6 Challenges of Protein Microarray Technologies
2.5.7 Emerging Microarray Technologies
Chapter 4 Impact of COVID-19 Pandemic
4.1 Impact of COVID-19 on the Microarray Technologies Market
4.1.1 Invention of a Microarray for Coronavirus Antigen
4.1.2 Determination of SARS-CoV-2 Convalescent Blood Specimens Using CoVAM
4.1.3 Methods for Testing COVID-19
4.1.4 SARS-CoV-2 Research Products
Chapter 5 Global Microarray Market by Product Type
5.2 DNA Microarrays
5.3 Protein Microarrays
5.4 Other Microarrays
5.4.1 Market Drivers
Chapter 6 Global Microarray Market
6.2 North America
6.5 Rest of the World
Chapter 7 Global Microarray Market by Application
7.1.1 Challenges in Drug Development
7.1.2 Drug Discovery and Development Process
7.1.3 Identification of Drug Target
7.1.4 Drug Discovery
7.2 Diagnostics Applications
7.2.1 Diagnostics Tools Differ from Research Tools
7.3 Clinical Diagnostic Indications
7.4 Cancer Clinical Diagnostics
7.4.1 Lung Cancer
7.4.2 Breast Cancer
7.4.3 Colorectal Cancer
7.4.5 Other Cancers
7.4.6 Oncology Screening/Early Detection
7.4.7 Oncology Diagnosis
7.4.8 Oncology Therapy Guidance
7.4.9 Oncology Monitoring
Chapter 8 Company Profiles
ADVANCED CELL DIAGNOSTICS INC.
BECTON, DICKINSON AND CO.
BENITEC BIOPHARMA LTD.
DEPUY SYNTHES (J&J)
DRÄGERWERK AG & CO. KGAA
EPIC SCIENCES INC.
INEX INNOVATIONS EXCHANGE PTE. LTD.
INTERPACE DIAGNOSTICS LLC.
ONCOMED PHARMACEUTICALS INC.
PLURISTEM THERAPEUTICS INC.
SILICON BIOSYSTEMS S.P.A
SPHERE FLUIDICS LTD.
THERMO FISHER SCIENTIFIC
Chapter 9 Patent Reviews
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.